Answers are grounded in this paper and cite their sources.
Lipid oxidation is now thought to be an initiating and sustaining event in atherogenesis. Oxidatively fragmented phospholipids, namely 1-palmitoyl-2-glutaroyl-sn-glycero-3-phosphocholine (PGPC) and 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphocholine (POVPC), present in minimally modified LDL and atherosclerotic lesions, have been reported to elicit a wide range of pathophysiological responses in the cells of the vascular wall. Nevertheless, the question of their potential sites of action and their primary molecular targets remains open. To address this issue, a series of fluorescently labeled analogs, which differ with regard to structure and binding site of the fluorophore, were synthesized and used as tools for studying the uptake, intracellular stability, and distribution of PGPC and POVPC in vascular smooth muscle cells (VSMCs). We demonstrate that in accordance with their lysophospholipid-like structure, these highly similar molecules transferred rapidly either from aqueous phospholipid dispersions or preloaded native LDL into VSMCs, producing disparate fluorescence patterns irrespective of the attached fluorophore. PGPC derivatives were translocated to the lysosomes. In sharp contrast, POVPC analogs were initially captured in the plasma membrane, most likely in consequence of the formation of covalent adducts with free amino and sulfhydryl groups of proteins and phospholipids. LDL internalization is not required for cellular lipid uptake. Collectively, our data provide evidence that oxidized phospholipids, owing to their high exchangeability between lipoproteins and cell membranes, may act within a short time on different cellular sites in VSMCs and affect various lipid and protein components through physical or chemical interactions, which might then serve as starting points for intracellular signaling. Lipid oxidation is now thought to be an initiating and sustaining event in atherogenesis. Oxidatively fragmented phospholipids, namely 1-palmitoyl-2-glutaroyl-sn-glycero-3-phosphocholine (PGPC) and 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphocholine (POVPC), present in minimally modified LDL and atherosclerotic lesions, have been reported to elicit a wide range of pathophysiological responses in the cells of the vascular wall. Nevertheless, the question of their potential sites of action and their primary molecular targets remains open. To address this issue, a series of fluorescently labeled analogs, which differ with regard to structure and binding site of the fluorophore, were synthesized and used as tools for studying the uptake, intracellular stability, and distribution of PGPC and POVPC in vascular smooth muscle cells (VSMCs). We demonstrate that in accordance with their lysophospholipid-like structure, these highly similar molecules transferred rapidly either from aqueous phospholipid dispersions or preloaded native LDL into VSMCs, producing disparate fluorescence patterns irrespective of the attached fluorophore. PGPC derivatives were translocated to the lysosomes. In sharp contrast, POVPC analogs were initially captured in the plasma membrane, most likely in consequence of the formation of covalent adducts with free amino and sulfhydryl groups of proteins and phospholipids. LDL internalization is not required for cellular lipid uptake. Collectively, our data provide evidence that oxidized phospholipids, owing to their high exchangeability between lipoproteins and cell membranes, may act within a short time on different cellular sites in VSMCs and affect various lipid and protein components through physical or chemical interactions, which might then serve as starting points for intracellular signaling. Oxidative modification of LDL is considered an important pathogenetic factor in atherosclerosis (1Steinberg D. Parthasarathy S. Carew T.E. Khoo J.C. Witztum J.L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 1989; 320: 915-924Google Scholar, 2Witztum J.L. Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 1991; 88: 1785-1792Crossref PubMed Scopus (2473) Google Scholar, 3Berliner J.A. Navab M. Fogelman A.M. Frank J.S. Demer L.L. Edwards P.A. Watson A.D. Lusis A.J. Atherosclerosis. Basic mechanisms: oxidation, inflammation, and genetics. Circulation. 1995; 91: 2488-2496Google Scholar). Preferential targets of oxidative attack are the esterified polyunsaturated fatty acids in the phospholipids of biological membranes and the shell that surrounds the insoluble lipids of lipoproteins (4Marathe G.K. Prescott S.M. Zimmerman G.A. McIntyre T.M. Oxidized LDL contains inflammatory PAF-like phospholipids. Trends Cardiovasc. Med. 2001; 11: 139-142Crossref PubMed Scopus (101) Google Scholar). Oxidative fragmentation of arachidonoyl phospholipids results in shortened sn-2 residues with or without ω-aldehydic, ω-hydroxy, or ω-carboxy functions (5Itabe H. Kushi Y. Handa S. of as of the of Scholar, H. S. H. of phospholipids lipid PubMed Scopus Google Scholar). are in oxidation of N. H. N. similar oxidized phospholipids binding of and Scholar, A.D. Navab M. Prescott S.M. McIntyre T.M. Fogelman A.M. J.A. of on the formation and action of minimally oxidized low density J. Clin. Invest. 1995; Scholar). been that the sn-2 of these are of their N. H. Watson A.D. Fogelman A.M. J.A. of of oxidized oxidized fatty groups the sn-2 Scholar). from have that the biological minimally modified LDL be to phospholipid oxidation N. H. N. similar oxidized phospholipids binding of and Scholar, A.D. Navab M. Prescott S.M. McIntyre T.M. Fogelman A.M. J.A. of on the formation and action of minimally oxidized low density J. Clin. Invest. 1995; Scholar, N. Watson A.D. Fogelman A.M. J.A. binding to cells oxidized phospholipids present in minimally oxidized low density lipoprotein is a factor Med. Scholar, Oxidized phospholipids in minimally modified low density lipoprotein of in smooth muscle J. Scholar). in atherosclerotic A.D. N. Navab M. S. Witztum J.L. D. of oxidized phospholipids in minimally oxidized low density lipoprotein that and evidence for their in J. Scholar, H. H. J. Y. oxidized lipoprotein cells in atherosclerotic formation of oxidized and J. and the oxidized phospholipids in and with S. H. N. J.A. for oxidized phospholipids or oxidized adducts of oxidized low-density J. Clin. Invest. Scholar, Witztum J.L. of oxidized LDL in LDL with 1995; Scholar, S. Witztum J.L. of to of oxidized lipoproteins from of of oxidized low density lipoprotein in J. Clin. Invest. to the of these rapidly been on in the series of oxidized phospholipids, namely 1-palmitoyl-2-glutaroyl-sn-glycero-3-phosphocholine (PGPC) and 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphocholine is the that in vascular cells that may to the of atherosclerosis as as inflammatory is in of their high to a a and the sn-2 different cellular PGPC and POVPC N. H. N. similar oxidized phospholipids binding of and Scholar, J. N. of inflammatory oxidized phospholipids in in with of Scholar, S. S. Navab M. Fogelman A.M. protein is for oxidized phospholipids to in J. 2001; Scholar, M. J. phospholipid oxidation of and increase the of as Navab M. N. Fogelman A.M. Lusis A.J. of the oxidized J. Clin. Invest. Scholar). In vascular smooth muscle cells POVPC to a PGPC the of Oxidized phospholipids in minimally modified low density lipoprotein of in smooth muscle J. Scholar). VSMCs a of different in to in a of or G.K. of of vascular smooth muscle 1995; Scholar, S. and of vascular smooth muscle cells in J. PubMed Scopus Google oxidized phospholipids Oxidized phospholipids in minimally modified low density lipoprotein of in smooth muscle J. Scholar, S. S. Navab M. Fogelman A.M. protein is for oxidized phospholipids to in J. 2001; Scholar, S. of vascular smooth muscle cells is for their oxidized phospholipids and their Scholar). the primary molecular targets and the of their these molecules are of the cell that oxidized phospholipids is of in the of action which cellular to into the intracellular and potential targets of PGPC and POVPC in this synthesized different analogs of the oxidized phospholipids. fluorescence of phospholipid with regard to their intracellular PGPC derivatives were initially transferred to to and to the labeled POVPC highly in the plasma time data the that protein and lipid sites in VSMCs that are their with oxidized phospholipids, initiating intracellular signaling. for lipid from in and from in were from and were from for were from for the protein from and were from and were from and for cell were from for protein were from smooth muscle cells smooth were in with and in a with phospholipids were in in a cells with to of the labeled lipids were dispersions of these in with the of on with of used as the were or with J.C. for the of phospholipids on J. Lipid or on of of the phospholipids were in a and of lipids were S. of phospholipids and of or of the PGPC synthesized to a modified of the of Watson A.D. N. Navab M. S. Witztum J.L. D. of oxidized phospholipids in minimally oxidized low density lipoprotein that and evidence for their in J. and and Watson A.D. J.A. of phospholipid and Med. Scholar). of and in of with as a and the of of with of of the with of of the of PGPC of PGPC in an of of and of a and the of of with of with of to and to and from the with of the the To a of in of were and the with and from and the for of the a a of from which the lipid the and from the with from the to to contains of on its from and in of the of for from of the with as a and with and with of the a of of and in of for to the to of of and of and then with were with and for the which used for the without and were to this of the of of the with and of were the of on of with as a to of the lipid as for the of PGPC to as a to a of and in of for which for the without of the of this with of the with of the with of with of and to of as a and were in of for and the a of in of the the and with were to the To a of in a of of and of were of the the from the aqueous with were and the high to of a of and free with of the of the in as a and were to a of the in of of the on of with to in as a with in of and of the the the of of with and the and with of the to a of with of of the of of in to the of producing of and were to a of in of the the and with were to on a with a and a were the were in the with an of and with a of were of the the and in a of of the on the and to of were to the in this to the most of LDL from plasma of density as J.C. and of plasma density in a J. Lipid and within of is in of protein which the of with the J. PubMed Google Scholar). with as reported of with a fluorescence J. Lipid Scholar). LDL with phospholipids, of or of in and transferred into a the a of the lipid with of LDL protein in of and for in the to with cell to a of for protein for and protein for of cells were to low in in on and the of the were with from for the analogs and to for and to for and cells were with and with an fluorescence with a a and a the the cells were used to in a series of were and for a of and for of these as the as the labeled phospholipids were in to a of for the analogs and for the were between the of either or in In as the in a labeled phospholipids were in to a of for the analogs and for the were between the of either or in To the of in the and intracellular distribution of the oxidized phospholipids, were for and with LDL either or that been preloaded with or cells were with and with the fluorescence were for and for these were that between and the were a with a an a and a were a and To the that cells for with a an or a in with and with for the cells with the transferred into an and with the fluorescence with were with which is to into the of the cell membrane, this cells were with for a with the fluorescence of the labeled phospholipid in an with the fluorescence of the of the cells with in without for cells were with and were from the cells were and for the phospholipids, for the and and for the and with the and the of cells in for were not with these or the of for fluorescence with as for a of cells in in the for with of a in with and cells were with and then into of with and were were for in of cell for on of and were to a of To and the and for of in to the to a of of for were of cell protein were a on the of and for the of of protein the of Scholar). of protein to and D. for the of protein in in the of and Scholar). protein in of and for were to in and J. PubMed Scopus Google N. S. of of Scholar, M. M. and of Scholar). and were as S. J. with in in the and to the Scholar, S. of with were were in a a of were in for were with the a of from fluorescence an for and a for the of protein patterns were to the for the were the as that a used as the of cells in were with the analogs of PGPC POVPC or in of for and cells were with of into of with a and then transferred into a with an of cell were and for the cellular lipids were a of and J. M. for the and of lipids from J. Scholar). cell in of and for with of a in and for the and to In the of lipids were with in a of of and of and S. S. as the of oxidized low density lipoprotein J. 2001; to the of adducts to lipids were from the aqueous with of the lipid were to as a and as and of were with a an of for data cells high in were with in of for Lipid as of the to to S. Steinberg D. Witztum J.L. of with the structure of oxidized phospholipids. of formation and J. in the of lipids to of were a and to and as in the and lipids were the of with a as smooth muscle cells were on with for and cells were with or PGPC for of the smooth muscle cells with the cells were with and with for the of a as Watson A.D. J.A. of phospholipid and Med. Scholar). of cell of protein were for of fluorescently labeled phospholipids a or to their with and PGPC derivatives were from PGPC and of with of covalent of a to the and of the of the of with analogs of and were starting from which to the of this with or the of or of with a of which and derivatives were as in and In the molecular and were of the for the of that are in of in the of the synthesized and analogs analogs of and are in to the most of is used as an for with and groups in the of the for and for in a of and are in to the most of is used as an for with and groups in the of the for and for of the derivatives the in the of be as a N. J. M. 1991; from the of an that a of which to the that that be to were in the of and which used In to the the an that be to the of in the of results that that were in the of the synthesized phospholipids are the and that of the labeled phospholipids an of and for of the molecular in phospholipids a and and be that of either to the not affect their of POVPC and its and analogs are have in a the sn-2 and a of the of or phospholipids into VSMCs, used to that analogs of PGPC and POVPC were in the of within not cells responses in of cell and of and Scholar, J. J.C. of cell without with cell J. 1995; in the time and range of the oxidized phospholipids, an of In this used and lipid analogs for the of lipid into the cells to potential of the fluorophore. were between the fluorescence of the PGPC analogs and the POVPC analogs In this to be that fluorescence is in is to the of a the are fluorescence to a the the of plasma fluorescence are with not with intracellular of fluorescence in the with to cells a as short as for the of to a of fluorescence in this intracellular of the plasma not of similar to that cells were with time in to the cell and in the in an and of and analogs into vascular smooth muscle cells (VSMCs). cells were with or or and or in for or with and fluorescence of VSMCs with without for be for the for are of cells for time in or with the of the a were and derivatives of oxidized phospholipids are rapidly VSMCs, in to their the in their intracellular PGPC analogs are initially transferred to in POVPC fluorescence highly in the plasma short is a high between from phospholipid of the and the binding site of the an of the fluorescence patterns of and the of the which is of lipid to the lysosomes. with an that the PGPC analogs of a with of with the in the of the lipid of high fluorescence in the plasma of this the plasma and the the cell the of PubMed Scopus Google Scholar). fluorescence of with the which is to into the of the plasma of a with not the fluorescence as its the plasma is likely to the that high in the may with a with the Engl. Scopus Google Scholar). analogs or as with were not the cells in the time in a different intracellular distribution In is that oxidized phospholipids into cells and are to different with the phospholipids. In to dispersions of oxidized phospholipids, used LDL as a for the of these into were with LDL a of the labeled lipid transferred to cells of intracellular fluorescence similar to that dispersions to an of fluorescence in the with a in the plasma In contrast, different were cells were with LDL preloaded with with lipid as the of lipid and the distribution different the LDL the of and distribution of the POVPC in In a to the of LDL in oxidized phospholipids to vascular with LDL labeled with and of PGPC and POVPC in the lipid and intracellular of the phospholipids with in which the lipid In this is important to that lipid fluorescence LDL be cells used in these were not and low of the LDL this to the of the lipid into the which to be different for the PGPC and POVPC Lipid of cells with of this in lipid to the on to the of the to the fluorescence lipid fluorescence is fluorescence of in is not in the fluorescence of the lipid to from lipids labeled with in the J. and of the in the of with the amino of and these are for is likely to be the cells with the a a of that have not been and are to of the of the modified lipids with from of with and not fluorescence patterns in the is that the might with S. Steinberg D. Witztum J.L. of with the structure of oxidized phospholipids. of formation and J. and adducts with cellular lipids and S. S. as the of oxidized low density lipoprotein J. 2001; Scholar, M. of structure and on the and of lipid 1991; Scholar). In of protein from cells with to covalent adducts of the oxidized lipid with cellular primary molecular targets of phospholipids and are to To address the question of the cellular distribution of the lipid analogs the of their in a their on the of which is a of the PGPC and POVPC Oxidized phospholipids in minimally modified low density lipoprotein of in smooth muscle J. Scholar). data in that PGPC and POVPC as as the analogs and the in In this the uptake, and modification of different fluorescently labeled derivatives of and in were in to demonstrate the phospholipids are into cells without with the the biological of a on the of the labeled with the lipids and proteins in the of PGPC and POVPC in oxidized phospholipids POVPC and PGPC and in vascular smooth muscle Scholar). phospholipids were to be in within of the lipids were have a of the as as their the lipid into cells of the labeled lipids into the cells is and within fluorescence on the this that the oxidized is into the plasma within and plasma of the biological of and protein Oxidized phospholipids in minimally modified low density lipoprotein of in smooth muscle J. within a of the oxidized lipids to the cells in which and intracellular of the oxidized phospholipid is Nevertheless, a be to the and of and its components lipoproteins that are to the and of the oxidized phospholipids into is in our To or the of the fluorophore, synthesized to labeled analogs to the of our In these a high on and of the to the of the as as of its high fluorescence and of its to the of the phospholipid to the which to be for In contrast, the of analogs not for have the of a the of the in a membrane, the most likely in the of the the molecular be J. and of the in the of with the amino of and Scholar). fluorescence high between data from the phospholipid different may be that the be to of the lipid molecules to the attached is not the derivatives and their in are a and an of which in high this into be that oxidized phospholipids are rapidly between membranes have cells or lipid are with the lipid between membranes of phospholipids into the plasma of a J. Scholar). for this been to be of lipid of lipid between Scholar). is likely that the of the oxidized phospholipids between the and cells is the the oxidized phospholipids are as that of oxidized phospholipids, a of in aqueous A.M. of of aqueous the of the oxidized lipids the used fluorescence of PGPC analogs VSMCs, in a distribution not that a of the plasma as which intracellular membranes are labeled PGPC derivatives is is that PGPC derivatives are to the either or of membranes may be the of lipid be the that the of in VSMCs is the of to the as the to the that the which been to be PGPC within Oxidized phospholipids in minimally modified low density lipoprotein of in smooth muscle J. be without to molecules of the oxidized Nevertheless, be that the of fluorescence from the of in which of the plasma an intracellular of fluorescence cells were with the for short of time as a consequence of covalent with amino and groups in lipids and that are to with amino groups of and and with sulfhydryl groups of proteins and to the formation of adducts with cellular proteins oxidative H. H. and of and Med. 1991; 11: Scholar, H. of protein adducts in oxidized PubMed Scopus Google Scholar). to this is the that the factor and its through of amino groups M. an factor for J. Scholar, J. of oxidized J. Scholar). the the of were to the amino groups of and to adducts M. of structure and on the and of lipid 1991; Scholar). S. S. as the of oxidized low density lipoprotein J. 2001; that adducts between and in oxidized LDL the of In the of the that of the of amino groups LDL oxidation might be to with phospholipid as now that demonstrate covalent formation between oxidized phospholipids and H. H. J. Y. oxidized lipoprotein cells in atherosclerotic formation of oxidized and J. Scholar, S. S. as the of oxidized low density lipoprotein J. 2001; Scholar, S. Witztum J.L. Steinberg D. Oxidized phospholipids, to of oxidized are for J. Lipid Scholar). In this evidence that with cellular protein be of cell protein In that of cell lipid modified In that POVPC is rapidly into the plasma of VSMCs its with the cell in covalent with lipids and and is in transferred in the of to to the is the that the that oxidized phospholipids are to VSMCs on their and intracellular LDL with the analogs of PGPC a fluorescence similar to that cells were with aqueous dispersions of the In contrast, the of with that of the free with LDL the were with which that LDL the cell J.L. of of a Scholar). LDL internalization is in the and lipid lipid to a the phospholipids are between different lipoprotein cellular In this their of action a cell or biological from their sites of is in with the results of J. in oxidized LDL not to are the Med. that oxidized phospholipids not to within oxidized LDL to native LDL and this be considered important of Oxidized phospholipids in minimally modified low density lipoprotein of in smooth muscle J. oxidative in of biological as the that oxidized phospholipids are between oxidized LDL and may to functions in the of atherosclerosis of adducts Cardiovasc. Scholar). In to the cellular to PGPC are to its is that PGPC is of lipid not in in as or PubMed Scopus Google Scholar). may be to and through factor and and 11: PubMed Scopus Google Scholar). may be the cellular of as the of to in the lipid M. of lipids on structure and PubMed Scopus Google Scholar). in the of have been to a in the of proteins and lipids into different of intracellular Lipid in Scholar, in cell in the physical of PGPC with cellular components or the of that through to of the In the physical and covalent modification of cellular components oxidized phospholipids which the of various and the of a wide range of biological PGPC and POVPC have been reported to elicit in VSMCs Oxidized phospholipids in minimally modified low density lipoprotein of in smooth muscle J. Scholar). that to be the of their primary molecular demonstrate the of sites for oxidized phospholipids on the cell as as is to the that might be different M. J. phospholipid oxidation of and Scholar, N. S. M. J.A. in the oxidized of a for and a J. that the of oxidized is a protein that with the of in and M. J.A. S. Lusis A.J. S. D. Watson A.D. and the inflammatory oxidized phospholipids. 2001; PubMed Scopus Google that POVPC and PGPC elicit their cellular responses through binding to different to that the of oxidized phospholipids are of their cellular responses factor a for this in VSMCs, and N. Watson A.D. Fogelman A.M. J.A. binding to cells oxidized phospholipids present in minimally oxidized low density lipoprotein is a factor Med. Scholar, M. Zimmerman G.A. McIntyre T.M. Prescott S.M. Oxidatively modified LDL contains phospholipids with and the of smooth muscle J. Clin. Invest. 1995; Scholar, H. S. M. of and with and without Scholar, Prescott S.M. Zimmerman G.A. McIntyre T.M. Oxidatively fragmented through the for J. 1991; Scholar). N. J.A. that phospholipid oxidation factor an important in in and in have evidence that the in of POVPC and lipid present in minimally modified LDL A.D. Navab M. Fogelman A.M. J.A. of a phospholipid in oxidized low density J. are not the factor not a for in the action of these molecules and that might a for POVPC and We the of proteins in oxidized phospholipids, in the of the data the of for these and the that the of the from different with components of their is with the results of S. of vascular smooth muscle cells is for their oxidized phospholipids and their that oxidized phospholipids in VSMCs is and not through are to the the pathophysiological of oxidized phospholipids on of their primary molecular targets is the of of of the and components in the of vascular cells oxidized lipid have a on and of atherogenesis. for with are to for with the from the and 1-palmitoyl-2-glutaroyl-sn-glycero-3-phosphocholine 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphocholine vascular smooth muscle cell
No takes yet. Share an insight, caveat, or question.
Moumtzi et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: